1. Home
  2. BNC vs BDSX Comparison

BNC vs BDSX Comparison

Compare BNC & BDSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CEA Industries Inc.

BNC

CEA Industries Inc.

HOLD

Current Price

$5.34

Market Cap

287.3M

Sector

Industrials

ML Signal

HOLD

Logo Biodesix Inc.

BDSX

Biodesix Inc.

HOLD

Current Price

$21.54

Market Cap

276.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BNC
BDSX
Founded
N/A
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Precision Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
287.3M
276.2M
IPO Year
2010
2020

Fundamental Metrics

Financial Performance
Metric
BNC
BDSX
Price
$5.34
$21.54
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
★ $39.00
AVG Volume (30 Days)
★ 835.4K
90.6K
Earning Date
09-11-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 159.72
N/A
EPS
★ N/A
N/A
Revenue
$9,581,968.00
★ $88,499,000.00
Revenue This Year
$27.15
$26.51
Revenue Next Year
$6.70
$20.25
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 32.89
24.08
52 Week Low
$1.84
$5.26
52 Week High
$7.99
$31.97

Technical Indicators

Market Signals
Indicator
BNC
BDSX
Relative Strength Index (RSI) 52.72 31.27
Support Level $2.15 $19.26
Resistance Level $5.58 $24.82
Average True Range (ATR) 0.25 1.58
MACD -0.06 -0.46
Stochastic Oscillator 55.24 1.25

Price Performance

Historical Comparison
BNC
BDSX

About BNC CEA Industries Inc.

CEA Industries Inc through its subsidiary is focused on selling environmental control and other technologies and services to the Controlled Environment Agriculture ("CEA") industry. The company provides integrated mechanical, electrical, and plumbing ("MEP") engineering design, proprietary and curated environmental control equipment, and automation offerings that serve the CEA industry. The Company has one operating segment that is dedicated to the manufacture and sale of its products.

About BDSX Biodesix Inc.

Biodesix Inc is a diagnostic solutions company with a focus on lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources: providing diagnostic testing services associated with blood-based lung and COVID tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties, as well as the development and commercialization of companion diagnostics.

Share on Social Networks: